TEVA TEVA PHARMACEUTICAL INDS LTD
FollowADR (ADR), issuer CIK 818686
Filings received so far for Q3 2026: 2 13F filers report a position in TEVA shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| CACTI ASSET MANAGEMENT LLC | 9,000 | $351K | 0.02% | 0 | 13F-HRTimeline |
| Byrne Asset Management LLC | 340 | $13.4K | 0.01% | -100 | 13F-HRTimeline |
Events
Bergwerk Dov reported holdings of TEVA shares in a Form 3 filed 2026-10-08. 0001193125-26-417902
Accepted , ingested